Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5415-5422

  Rao, D Sudhaker ^a   Phillips, Evelyn R ^a   Divine, George W ^a   Talpos, Gary B ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ANXIETY; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CERVICAL SPINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EMOTIONAL STRESS; FATIGUE; FEMALE; FEMUR NECK; FOLLOW UP; FOREARM; FRACTURE; HEALTH SURVEY; HUMAN; HYPERPARATHYROIDISM; IRRITABILITY; KIDNEY DISEASE; LUMBOSACRAL SPINE; MALE; NEPHROLITHIASIS; OSTEOLYSIS; PANCREATITIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT SATISFACTION; PHOBIA; PHYSICAL DISABILITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENT DISEASE; SELF CONCEPT; SOCIAL INTERACTION; SURGICAL RISK; THORACIC SPINE; TREATMENT OUTCOME;

ADULT; BONE DENSITY; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 8744257804     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0028     Document Type: Article

References (62)

1. NIH Consensus Development Panel 1991 Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement. Ann Intern Med 114:593-597
2. Kleerkoper M, Belezikian JP 1994 A cure in search of a disease: parathyroidectomy for nontraditional features of primary hyperparathyroidism. Am J Med 96:99-106
3. Toft AD 2000 Surgery for primary hyperparathyroidism - sooner rather than later. Lancet 355:1478-1479
4. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF 1999 Therapeutic controversy: therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 84:2275-2285
5. Rastad J 2001 Parathyroidectomy in "asymptomatic" primary hyperparathyroidism: the endless debate on an imaginary patient group. J Endocrinol Invest 24:56-61
6. Rao DS 2001 Parathyroidectomy for asymptomatic primary hyperparathyroidism: is it worth the risk? J Endocrinol Invest 24:131-134
7. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM 1988 Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294-1298
8. Parfitt AM, Rao DS, Kleerekoper M 1991 Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 6(Suppl 2):S97-S101, discussion S121-S124
9. Posen S, Clifton-Bligh P, Reeve TS, Wagstaffe C, Wilkinson M 1985 Is parathyroidectomy of benefit in primary hyperparathyroidism? Q J Med 54:241-251
10. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255
11. Rao DS, Phillips E, Jacobsen G, Divine G 1994 Natural history of untreated mild primary hyperparathyroidism (PHPT): first five year results of a prospective clinical study. J Bone Miner Res 9:S423
12. Scholz DA, Purnell DC 1981 Asymptomatic primary hyperparathyroidism: 10-year prospective study. Mayo Clin Proc 56:473-478
13. Kleerekoper M, Rao DS, Talpos GB, Bone HG 1991 Management of asymptomatic primary hyperparathyroidism. Adv Endocrinol Metab 2:205-220
14. Mole PA, Walkinshaw MH, Gunn A, Paterson CR 1992 Bone mineral content in patients with primary hyperparathyroidism: a comparison of conservative management with surgical treatment. Br J Surg 79:263-265
15. Clyde JW, Wittert GA, Gilchrist NL, Turner JG, Donald RA, Espiner EA 1992 The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism. NZ Med J 105:71-72
16. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, McMahon DJ, Bilezikian JP 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80:729-734
17. Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson TA, Nordenstrom J 1995 Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg 161:863-869
18. Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid I 1996 Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 125:360-368
19. Grey AB, Stapleton JP, Evans MC, Reid IR 1996 Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin Endocrinol (Oxf) 44:697-702
20. Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R 1996 Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 81:3487-3491
21. Diamond T, Ng AT, Levy S, Magarey C, Smart R 1996 Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos Int 6:329-333
22. Delbridge LW, Younes NA, Guinea AI, Reeve TS, Clifton-Bligh P, Robinson BG 1998 Surgery for primary hyperparathyroidism 1962-1996: indications and outcomes. Med J Aust 168:153-156
23. Fuleihan GE-H, Moore Jr FD, LeBoff MS, Hurwitz S, Gundberg CM, Angell J, Scott J 1999 Longitudinal changes in bone density in hyperparathyroidism. J Clin Densitom 2:153-162
24. Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM 2003 Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol (Oxf) 58:348-354
25. Rao DS, Rao SD 2003 Treatment of primary hyperparathyroidism. Curr Opin Endocrinol Diabetes 10:394-399
26. Coe F, Favus M 1980 Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med 302:224-225
27. Irvin GLI, Carneiro DM 2000 Management changes in primary hyperparathyroidism. JAMA 284:934-936
28. Silverberg SJ, Locker FG, Bilezikian JP 1996 Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007-4012
29. Silverberg SJ, Brown I, Bilezikian JP 2002 Age as a criterion for surgery in primary hyperparathyroidism. Am J Med 113:681-684
30. Bilezikian JP, Potts Jr JT, Fuleihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353-5361
31. Parfitt AM, Podenphant J, Villanueva AR, Frame B 1985 Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 6:211-220
32. Goode AW, Jenkins BJ, Monson JP, Sprague DB, Donaldson PJ, Toms GC 1987 The β2 microglobulin urine to serum ratio: an early marker of renal dysfunction in primary hyperparathyroidism. Surgery 102:914-916
33. Ware JE, Sherbourne CD 1992 The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483
34. McHorney CA, Ware Jr JE, Raczek AE 1993 The MOS 36-item Short-Form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263
35. Derogatis LR, Rickels K, Rock AF 1976 The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 128:280-289
36. Rao DS, Alam M, Maciejko JJ, Phillips E, Divine GW, Talpos GB 1998 Cardiac function and lipid profile in mild asymptomatic primary hyperparathyroidism: effect in a randomized trial of parathyroidectomy. Bone 23:S380
37. Rao DS, Han Z-H, Phillips ER, Honasoge M, Palnitkar S, Parikh N, Talpos GB 1998 Mild primary hyperparathyroidism (PHPT) is associated with attenuation of skeletal effects of estrogen depletion (-E). Bone 23:S381
38. Farley JR, Kyeyune-Nyombi E, Tarbaux NM, Hall SL, Strong DD 1989 Alkaline phosphatase activity from human osteosarcoma cell line SaOS-2: an isoenzyme standard for quantifying skeletal alkaline phosphatase activity in serum. Clin Chem 35:223-229
39. Peduzzi P, Wittes J, Detre K, Holford T 1993 Analysis of as-randomized and the problem of non-adherence: an example from the veterans affairs randomized trial of coronary artery bypass surgery. Stat Med 12:1185-1195
40. Burton P, Gurrin I, Sly P 1998 Tutorial in biostatistics: extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modeling. Stat Med 17:1261-1291
41. SAS Institute 1999 I. SAS/STAT user's guide, version 8.0. Cary, NC: SAS Institute
42. Talpos GB, Bone HG, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS 2000 Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128:1013-1021
43. Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH 1987 Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond) 73:659-664
44. Parfitt AM 1976 The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts: PTH and osteoblasts, the relationship between bone turn-over and bone loss, and the state of bones in primary hyperparathyroidism. Metabolism 25:1033-1069
45. Rao OS, Parikh N, Phillips ER, Honasoge M, Talpos GB 2001 Higher serum PTH levels after parathyroidectomy (PTX) in patients with primary hyperparathyroidism (PHPT): implications for pathogenesis of the disease and relevance to PTH treatment in osteoporosis. J Bone Miner Res 16:S421
46. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH 1995 Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 222:402-412
47. Burney RE, Jones KR, Christy B, Thompson NW 1999 Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125:608-614
48. Turken SA, Cafferty M, Silverberg SJ, De La Cruz L, Cimino C, Lange DJ, Lovelace RE, Bilezikian JP 1989 Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87:553-557
49. Colliander EB, Strigard K, Westblad P, Rolf C, Nordenstrom J 1998 Muscle strength and endurance after surgery for primary hyperparathyroidism. Eur J Surg 164:489-494
50. Palmer M, Bergstrom R, Akerstrom G, Adami H, Jakobsson S, Ljunghall S 1987 Survival and renal function in untreated hypercalcemia: population-based cohort study with 14 years of follow-up. Lancet 1:59-62
51. Rubinoff H, McCarthy N, Hiatt RA 1983 Hypercalcemia: long-term follow-up with matched controls. J Chron Dis 36:859-868
52. Roka R, Niederle B, Kovarik J, Klaushofer K, Schernthaner G, Fritsch A 1987 Clinical long-term results after parathyroidectomy for primary hyperparathyroidism. Acta Chir Scand 153:513-520
53. Leppla DC, Snyder W, Pak CYC 1982 Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest Radiol 17:604-606
54. Martin P, Bergmann P, Gillet C, Fuss M, Corvilain J, van Geertruyden J 1990 Long-term irreversibiliry of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med 150:1495-1497
55. Corlew DS, Bryda SL, Bradley EL, DiGirolamo M 1985 Observations on the course of untreated primary hyperparathyroidism. Surgery 98:1064-1071
56. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, Bilezikian JP 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80:723-728
57. Wilson RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM 1988 Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109:959-962
58. Albright F, Reifenstein EC 1948 The parathyroid glands and metabolic bone diseases: selected studies. Baltimore: Williams, Wilkins Co.
59. Mithal A, Bandeira F, Meng X, Silverberg S, Shi Y, Mishra SK, Griz L, Macedo G, Celdas G, Bandeira C, Bilezikian JP, Rao DS 2001 Clinical presentation of primary hyperparathyroidism: India, Brazil and China. In: Bilezikian JP, Levine MA, Marcus R, eds. The parathyroids. San Diego: Academic Press; 375-386
60. Taylor KM, Margolese RG, Soskolne CL 1984 Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 310:1363-1367
61. Jones KR, Burney RE, Christy B 2000 Patient expectations for surgery: are they being met? Jt Comm J Qual Improv 26:349-360
62. Kleerekoper M, Nelson DA, Peterson EL, Flynn MJ, Pawluszka AS, Jacobsen G, Wilson P 1994 Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women. J Bone Miner Res 9:1267-1276